We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2201
DELISTED
Flushing Financial
FFIC
| $689K | ﹤0.01% |
59,787
-6,280
| -10% | -$71.9K |
|
2202
Hyster-Yale Materials Handling
HY
$665M
| $688K | ﹤0.01% |
17,791
-813
| -4% | -$30.3K |
|
2203
Applied Optoelectronics
AAOI
$11.5B
| $684K | ﹤0.01% |
62,919
-4,544
| -7% | -$41.6K |
|
2204
Geron
GERN
$949M
| $683K | ﹤0.01% |
313,306
+14,062
| +5% | +$21K |
|
2205
Ardelyx
ARDX
$997M
| $681K | ﹤0.01% |
98,450
+1,653
| +2% | +$11.5K |
|
2206
Impinj
PI
$5.6B
| $679K | ﹤0.01% |
24,725
+2,208
| +10% | +$51.7K |
|
|
PAE
2207
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $678K | ﹤0.01% |
+70,872
| New | +$631K |
|
|
ODT
2208
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $677K | ﹤0.01% |
15,984
+3,975
| +33% | +$129K |
|
|
EB
2209
DELISTED
Eventbrite
EB
| $675K | ﹤0.01% |
78,718
+33,840
| +75% | +$299K |
|
|
FLIC
2210
DELISTED
First of Long Island Corp
FLIC
| $670K | ﹤0.01% |
40,986
-4,050
| -9% | -$62.1K |
|
|
MEET
2211
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $670K | ﹤0.01% |
107,330
+3,685
| +4% | +$22.7K |
|
2212
Dime Commercial Bancshares
DCOM
$1.78B
| $669K | ﹤0.01% |
29,277
+308
| +1% | +$6.33K |
|
|
EVRI
2213
DELISTED
Everi Holdings
EVRI
| $669K | ﹤0.01% |
129,590
+37,854
| +41% | +$192K |
|
|
THR
2214
DELISTED
Thermon Group Holdings
THR
| $669K | ﹤0.01% |
45,918
+4,290
| +10% | +$63.5K |
|
2215
Barrett Business Services
BBSI
$804M
| $668K | ﹤0.01% |
50,280
+10,604
| +27% | +$123K |
|
2216
Arrow Financial
AROW
$652M
| $665K | ﹤0.01% |
25,171
-5,481
| -18% | -$134K |
|
2217
First Community Bankshares
FCBC
$911M
| $665K | ﹤0.01% |
29,638
-3,093
| -9% | -$67K |
|
|
NPKI
2218
NPK International
NPKI
$1.14B
| $665K | ﹤0.01% |
298,281
-20,060
| -6% | -$34K |
|
|
VBIV
2219
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $662K | ﹤0.01% |
7,115
+3,669
| +106% | +$202K |
|
|
STEL
2220
DELISTED
Stellar Bancorp
STEL
| $657K | ﹤0.01% |
31,283
-1,970
| -6% | -$36.5K |
|
|
PDLI
2221
DELISTED
PDL BioPharma, Inc.
PDLI
| $656K | ﹤0.01% |
225,328
+3,521
| +2% | +$11.1K |
|
2222
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
| $654K | ﹤0.01% |
+23,709
| New | +$644K |
|
2223
Ducommun
DCO
$2.98B
| $653K | ﹤0.01% |
18,728
+378
| +2% | +$11.2K |
|
2224
Q32 Bio
QTTB
$464M
| $651K | ﹤0.01% |
2,381
+767
| +48% | +$204K |
|
2225
Waterstone Financial
WSBF
$375M
| $650K | ﹤0.01% |
43,828
-3,273
| -7% | -$46.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.